1-year outcomes of patients implanted with the Perceval sutureless valve: the Japanese post-marketing surveillance study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1615-2573
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
1-year outcomes of patients implanted with the Perceval sutureless valve: the Japanese post-marketing surveillance study ; day:11 ; month:2 ; year:2023 ; pages:1-8
Heart and vessels ; (11.2.2023), 1-8
- Creator
-
Niinami, Hiroshi
Sawa, Yoshiki
Shimokawa, Tomoki
Domoto, Satoru
Nakamura, Yoshitsugu
Sakaguchi, Taichi
Ito, Toshiaki
Toda, Koichi
Amano, Atsushi
Gersak, Borut
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00380-023-02240-1
- URN
-
urn:nbn:de:101:1-2023041509122129271601
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Niinami, Hiroshi
- Sawa, Yoshiki
- Shimokawa, Tomoki
- Domoto, Satoru
- Nakamura, Yoshitsugu
- Sakaguchi, Taichi
- Ito, Toshiaki
- Toda, Koichi
- Amano, Atsushi
- Gersak, Borut
- SpringerLink (Online service)
Other Objects (12)
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study
Eculizumab for adult patients with atypical haemolytic-uraemic syndrome: full dataset analysis of Japanese post-marketing surveillance
Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-marketing surveillance of anti-malarial medicines used in Malawi
Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance
Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study
Eculizumab for adult patients with atypical haemolytic-uraemic syndrome: full dataset analysis of Japanese post-marketing surveillance
Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-marketing surveillance of anti-malarial medicines used in Malawi
Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance
Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study
Eculizumab for adult patients with atypical haemolytic-uraemic syndrome: full dataset analysis of Japanese post-marketing surveillance
Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-marketing surveillance of anti-malarial medicines used in Malawi
Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance
Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data